Organisation paid for research Program year 2024 Source: CMS Open Payments

Bond Clinic, PA

Neither a doctor nor a teaching hospital

Research payments

$79,681

9 payments

Through program year 2024, Bond Clinic, PA is reported as receiving $79,681 in research payments, across 9 payments.

By program year

5 rows
Year Kind Amount Payments
2024 Research $54,923 3
2023 Research $12,645 3
2021 Research $275 1
2020 Research $925 1
2019 Research $10,914 1

Breakdown

Who paid Research payments · program years 2019–2024
  1. AstraZeneca UK Limited $66,817 5 payments
  2. AstraZeneca Pharmaceuticals LP $10,914 1 payment
  3. Amgen Inc. $1,200 2 payments
  4. E.R. Squibb & Sons, L.L.C. $750 1 payment
Studies the money was for Research payments · program years 2019–2024
  1. A Phase 2 Open-label, Multicenter, Randomized, Multidrug Platform Study of Durvalumab (MEDI4736) Alone or in Combination with Novel Agents in Subjects with Locally Advanced, Unresectable, Stage III Non-small Cell Lung Cancer (COAST) $62,768 4 payments
  2. CAMBRIA1 A Phase III, OpenLabel,Randomised Study to Assess the Efficacy and Safety of Extended Therapy with Camizestrant AZD9833,a Next Generation, Oral Selective Estrogen Receptor Degrader vs Standard Endocrine Therapy Aromatase Inhibitor or Tamoxifen in Patients with ER HER2 Early Breast Cancer and an Intermediate or High Risk of Recurrence Who Have Completed Definitive Locoregional Therapy and at Least 2 Years of Standard Adjuvant Endocrin Based Therapy Without Disease Recurrence $10,000 1 payment
  3. CAMBRIA-1 A Phase III, Open-Label,Randomised Study to Assess the Efficacy and Safety of Extended Therapy with Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) in Patients with ER+/HER2 $4,964 1 payment
  4. Prospective Observational Study of Onpro vs SOC. $1,200 2 payments
  5. Connect Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study $750 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record